Hims & Hers Health Inc

HIMS

Company Profile

  • Business description

    Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

  • Contact

    2269 Chestnut Street
    Suite 523
    San FranciscoCA94123
    USA

    T: +1 415 851-0195

    https://www.forhims.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,637

Stocks News & Analysis

stocks

Palantir earnings: AI leadership intact; valuation still causes heartburn

Our view of Palantir Technologies.
stocks

Market underestimating cheap ASX share

Investors missing the big opportunity in batteries.
stocks

As Nvidia crosses $5 trillion, 5 charts on the unstoppable tech rally

Demand for AI has catapulted tech stocks into the stratosphere.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,071.2019.30-0.21%
CAC 408,074.236.700.08%
DAX 4024,048.8799.760.42%
Dow JONES (US)47,193.08107.840.23%
FTSE 1009,777.0862.120.64%
HKSE25,935.4116.99-0.07%
NASDAQ23,557.04208.400.89%
Nikkei 22550,212.271,284.93-2.50%
NZX 50 Index13,620.9815.020.11%
S&P 5006,811.8740.320.60%
S&P/ASX 2008,802.007.80-0.09%
SSE Composite Index3,969.259.060.23%

Market Movers